Towercrest Capital Management Phasebio Pharmaceuticals Inc C Call Options Transaction History
Towercrest Capital Management
- $619 Million
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|